Osafradu A. Opam

Osafradu Opam practices at Jamaica Hospital Medical Center in Jamaica, New York, part of MediSys Health Network.

Osafradu Opam's NPI, 1134289499, was assigned on December 9, 2006. Osafradu Opam graduated from State University of New York Downstate Medical Center College of Medicine in 1991. Osafradu Opam holds New York license 192310.

Osafradu Opam's primary practice is Jamaica Hospital Medical Center, at 89th Avenue and Van Wyck Expressway, Jamaica, NY 11418 in Queens County. The practice phone is (718) 262-6000. Osafradu Opam also practices at Jamaica Hospital Medical Center, 89- Van Wyck Expy, Richmond Hill, NY 11418.

Osafradu Opam's primary practice is Jamaica Hospital Medical Center in Jamaica, New York, part of MediSys Health Network. The medical group on file is Jamaica Hospital Medical Center. Dmand AI also links Osafradu Opam to 2 more physician offices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Osafradu Opam practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Osafradu Opam's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Osafradu Opam is licensed in New York.

CMS data shows 29 Medicare services from Osafradu Opam across 1 procedure code in 2024, all of them office visits, for 35 Medicare patients. Medicare paid $2,333 for them. Every service was in an office.

CMS counts 35 Medicare patients who saw Osafradu Opam in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Osafradu Opam's median patient age at 57, with 55% women.

In 2024, Osafradu Opam wrote 741 Medicare Part D claims for 105 patients. 73% of them were for generic drugs. CMS names the drug for 607 of them, across 20 drugs with 11 or more claims each, at $371,294 in total drug cost. In 2023, CMS named 652 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Osafradu Opam for performance year 2024, reported as part of a group. Osafradu Opam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 648 general payments to Osafradu Opam from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $1,756.

Osafradu Opam graduated from State University of New York Downstate Medical Center College of Medicine in 1991.